Wednesday 9 March 2016, 8AM PST, 11AM EST, 4PM GMT, 5PM CET
REGISTRATION LINK: http://www.workcast.com/register?cpak=5147343581778648&referrer=SPONSOR_PR_MotifBio With antibiotic resistance increasingly being acknowledged as a major public health threat, regulatory and policy initiatives and a growth in funding are now catalyzing the revitalization of R&D in the area. In this webcast, experts from several companies in the field will examine what is being done to combat antibiotic resistance, covering approaches including antibiotic-resistance breakers, macrocycles and other antibiotic classes for infections caused by key pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus.
The webcast will also include a roundtable discussion and a Q&A section to allow you to participate and contribute your own thoughts on efforts to tackle the emerging antibiotic resistance crisis.
Presenting Companies:
Motif Bio
Dr. David Huang
Chief Medical Officer
Antabio
Dr. Marc Lemonnier
Co-founder and CEO
Cempra Inc.
Dr. Prabhavathi Fernandes
Founder, President and CEO
Helperby Therapeutics
Professor Anthony R.M. Coates
Founder and Chief Scientific Officer
Polyphor
Dr. Glenn Dale
Head of Early Development, Antimicrobials
REGISTRATION LINK: http://www.workcast.com/register?cpak=5147343581778648&referrer=SPONSOR_PR_MotifBio With antibiotic resistance increasingly being acknowledged as a major public health threat, regulatory and policy initiatives and a growth in funding are now catalyzing the revitalization of R&D in the area. In this webcast, experts from several companies in the field will examine what is being done to combat antibiotic resistance, covering approaches including antibiotic-resistance breakers, macrocycles and other antibiotic classes for infections caused by key pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus.
The webcast will also include a roundtable discussion and a Q&A section to allow you to participate and contribute your own thoughts on efforts to tackle the emerging antibiotic resistance crisis.
Presenting Companies:
Motif Bio
Dr. David Huang
Chief Medical Officer
Antabio
Dr. Marc Lemonnier
Co-founder and CEO
Cempra Inc.
Dr. Prabhavathi Fernandes
Founder, President and CEO
Helperby Therapeutics
Professor Anthony R.M. Coates
Founder and Chief Scientific Officer
Polyphor
Dr. Glenn Dale
Head of Early Development, Antimicrobials
